1. At a Glance
India’s biggest eyecare chain with 25% market share, now listed and flexing a P/E of 170. Revenue FY25: ₹1,711 Cr, Net Profit: ₹110 Cr, yet no dividends. Investors stare at the stock and whisper – “premium vision, premium price.”
2. Introduction with Hook
If hospitals were Bollywood actors, Dr. Agarwal’s is the superstar charging ₹500 for a selfie. The chain’s growth is laser-sharp – revenue CAGR 26% over 5 years – but margins squint under high expansion costs. Eye surgeries are booming, but so is the P/E!
3. Business Model (WTF Do They Even Do?)
- Primary Biz: Eye-care services – cataract, refractive, glaucoma, retina, cornea.
- Secondary Biz: Optical products, lenses, pharma eye-care.
- Expansion Mode: Aggressive hospital additions pan-India.
Basically, they fix your vision while blinding you with the
